Kenvue Inc. Kenvue Inc.

Kenvue Inc.

KVUE

Pozycja w akcjach #671
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Cena akcji
$18.87
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$36.24B
Zmiana (1 dzień)
-0.11%
Zmiana (1 rok)
26.14%
Kraj
US
Handel Kenvue Inc. (KVUE)

Kategoria

Consumer Defensive
Historia dywidend dla Kenvue Inc. (KVUE)
Kenvue Inc. (symbol giełdowy: KVUE) wypłaciła łącznie 11 dywidend.
Suma wszystkich dywidend (skorygowana o podziały akcji): $2.24
Wskaźnik dywidendy (TTM): 0.0579
Wypłaty dywidend dla Kenvue Inc. (KVUE) od 2023 do 2026
Roczne wypłaty dywidend
Rok Dywidenda (skorygowana o podziały akcji) Zmień
2026 (TTM) $0.2075 -74.85%
2025 $0.825 1.85%
2024 $0.81 102.50%
2023 $0.4 0.00%
Lista wszystkich wypłat dywidend
Rok Dywidenda Zmień
2026 (TTM) $0.2075 -74.85%
2025 $0.825 1.85%
2024 $0.81 102.50%
2023 $0.4 0.00%
Wypłaty dywidend firm podobnych lub konkurencyjnych